Skip to content

Author

Shu-Li Yang

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Oct 2026

Case Report: SMARCA4-deficient uterine sarcoma with exceptional response to immune checkpoint inhibitor therapy

Background SMARCA4-deficient uterine sarcoma (SDUS) is a rare and aggressive undifferentiated uterine mesenchymal malignancy characterized by inactivation of SMARCA4 gene leading to loss of nuclear SMARCA4/BRG1 immunohistochemical staining. Fewer than 40 cases have been reported worldwide since its first description in...

Qun Liu, Hai-Li Kang, Jiao-Zhen Wang et al. · 0 citations
Open access Oct 2026

Cystathionine beta-synthase alleviates intervertebral disc degeneration by inhibiting ferroptosis of nucleus pulposus cells via the PI3K-AKT Axis.

Intervertebral disc degeneration (IVDD) is the leading cause of low back pain, affecting 619 million people worldwide in 2020, yet no effective disease-modifying therapy is clinically available to reverse its progression. Ferroptosis has been proven to be a core driver of IVDD by inducing injury to nucleus pulposus cel...

Chun-Mei Yang, Han-Feng Hu, Yang Yang et al. · 0 citations
Open access Oct 2026

Case Report: SMARCA4-deficient uterine sarcoma with exceptional response to immune checkpoint inhibitor therapy

SMARCA4-deficient uterine sarcoma (SDUS) is a rare and aggressive undifferentiated uterine mesenchymal malignancy characterized by inactivation of SMARCA4 gene leading to loss of nuclear SMARCA4/BRG1 immunohistochemical staining. Fewer than 40 cases have been reported worldwide since its first description in 2018,...

Qun Liu, Hai-Li Kang, Jiao-Zhen Wang et al. · 0 citations
Review Open access Aug 2026

Mechanism-Driven Evolution of Fertility-Sparing Treatment and Precision Management of Special Populations in Endometrial Cancer: A Review

How fertility-sparing treatment has expanded from oral progestin therapy alone to include local intrauterine therapy, hysteroscopic lesion resection, metabolic interventions, combined endocrine therapy, and selected molecularly guided strategies is described.

K. Qu, Chun-Lin Pan, Ming-Yue Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.